ICDO3_2;Level;Morphology;Phenotype;morphology_group;ICDO3_2_cropped
8000;Preferred;Neoplasm;mixed or multipotent stem cell;Neoplasm;0
8001;Preferred;Tumor cells;mixed or multipotent stem cell;Neoplasm;1
8002;Preferred;Malignant tumor small cell type;mixed or multipotent stem cell;Neoplasm;2
8003;Preferred;Malignant tumor giant cell type;mixed or multipotent stem cell;Neoplasm;3
8004;Preferred;Malignant tumor spindle cell type;mixed or multipotent stem cell;Neoplasm;4
8005;Preferred;Malignant tumor clear cell type;mixed or multipotent stem cell;Neoplasm;5
8010;Preferred;Carcinoma;epithelial;Carcinoma;10
8011;Preferred;Epithelioma;epithelial;Carcinoma;11
8012;Preferred;Large cell carcinoma;neuroectodermal;Neuroendocrine tumor;12
8013;Preferred;Large cell neuroendocrine carcinoma;neuroectodermal;Neuroendocrine tumor;13
8014;Preferred;Large cell carcinoma with rhabdoid phenotype;neuroectodermal;Neuroendocrine tumor;14
8015;Preferred;Glassy cell carcinoma;epithelial;Carcinoma;15
8020;Preferred;Carcinoma;epithelial;Carcinoma;20
8021;Preferred;Carcinoma;epithelial;Carcinoma;21
8022;Preferred;Pleomorphic carcinoma;epithelial;Carcinoma;22
8023;Preferred;Nuclear protein in testis (NUT) associated carcinoma;epithelial;Carcinoma;23
8030;Preferred;Giant cell and spindle cell carcinoma;epithelial;Carcinoma;30
8031;Preferred;Giant cell carcinoma;epithelial;Carcinoma;31
8032;Preferred;Spindle cell carcinoma;epithelial;Carcinoma;32
8033;Preferred;Pseudosarcomatous carcinoma;epithelial;Carcinoma;33
8034;Preferred;Polygonal cell carcinoma;epithelial;Carcinoma;34
8035;Preferred;Carcinoma with osteoclast-like giant cells;epithelial;Carcinoma;35
8041;Preferred;Small cell carcinoma;neuroectodermal;Neuroendocrine tumor;41
8042;Preferred;Oat cell carcinoma;neuroectodermal;Neuroendocrine tumor;42
8043;Preferred;Small cell carcinoma;neuroectodermal;Neuroendocrine tumor;43
8044;Preferred;Small cell carcinoma;neuroectodermal;Neuroendocrine tumor;44
8045;Preferred;Combined small cell carcinoma;neuroectodermal;Neuroendocrine tumor;45
8046;Preferred;Non-small cell carcinoma;epithelial;Carcinoma;46
8050;Preferred;Papillary carcinoma;epithelial;Carcinoma;50
8051;Preferred;Verrucous carcinoma;epithelial;Carcinoma;51
8052;Preferred;Papillary squamous cell carcinoma;epithelial;Squamous cell carcinoma;52
8054;Preferred;Warty carcinoma;epithelial;Squamous cell carcinoma;54
8070;Preferred;Squamous cell carcinoma;epithelial;Squamous cell carcinoma;70
8071;Preferred;Squamous cell carcinoma;epithelial;Squamous cell carcinoma;71
8072;Preferred;Squamous cell carcinoma;epithelial;Squamous cell carcinoma;72
8073;Preferred;Squamous cell carcinoma;epithelial;Squamous cell carcinoma;73
8074;Preferred;Squamous cell carcinoma;epithelial;Squamous cell carcinoma;74
8075;Preferred;Squamous cell carcinoma;epithelial;Squamous cell carcinoma;75
8076;Preferred;Squamous cell carcinoma;epithelial;Squamous cell carcinoma;76
8078;Preferred;Squamous cell carcinoma;epithelial;Squamous cell carcinoma;78
8082;Preferred;Lymphoepithelial carcinoma;epithelial;Lymphoepithelial carcinoma;82
8083;Preferred;Basaloid squamous cell carcinoma;epithelial;Squamous cell carcinoma;83
8084;Preferred;Squamous cell carcinoma;epithelial;Squamous cell carcinoma;84
8085;Preferred;Squamous cell carcinoma;epithelial;Squamous cell carcinoma;85
8086;Preferred;Squamous cell carcinoma;epithelial;Squamous cell carcinoma;86
8090;Preferred;Basal cell carcinoma;epithelial;Basal cell carcinoma;90
8091;Preferred;Basal cell carcinoma;epithelial;Basal cell carcinoma;91
8092;Preferred;Basal cell carcinoma;epithelial;Basal cell carcinoma;92
8093;Preferred;Basal cell carcinoma;epithelial;Basal cell carcinoma;93
8094;Preferred;Basosquamous carcinoma;epithelial;Squamous cell carcinoma;94
8095;Preferred;Metatypical carcinoma;epithelial;Carcinoma;95
8097;Preferred;Basal cell carcinoma;epithelial;Basal cell carcinoma;97
8098;Preferred;Basal cell carcinoma;epithelial;Adenoid basal carcinoma;98
8100;Preferred;Trichoblastic carcinoma;epithelial;Trichoblastic carcinoma;100
8102;Preferred;Trichilemmocarcinoma;epithelial;Trichilemmocarcinoma;102
8110;Preferred;Pilomatrical carcinoma;epithelial;Pilomatrical carcinoma;110
8120;Preferred;Transitional cell carcinoma;epithelial;Transitional cell carcinoma;120
8121;Preferred;Schneiderian carcinoma;epithelial;Transitional cell carcinoma;121
8122;Preferred;Urothelial carcinoma sarcomatoid ;epithelial;Transitional cell carcinoma;122
8123;Preferred;Basaloid carcinoma;epithelial;Transitional cell carcinoma;123
8124;Preferred;Cloacogenic carcinoma;epithelial;Transitional cell carcinoma;124
8130;Preferred;Papillary transitional cell carcinoma;epithelial;Transitional cell carcinoma;130
8131;Preferred;Urothelial carcinoma micropapillary;epithelial;Transitional cell carcinoma;131
8140;Preferred;Adenocarcinoma;epithelial;Adenocarcinoma;140
8141;Preferred;Scirrhous adenocarcinoma;epithelial;Adenocarcinoma;141
8142;Preferred;Linitis plastica;epithelial;Adenocarcinoma;142
8143;Preferred;Superficial spreading adenocarcinoma;epithelial;Adenocarcinoma;143
8144;Preferred;Adenocarcinoma intestinal type;epithelial;Adenocarcinoma;144
8145;Preferred;Carcinoma;epithelial;Adenocarcinoma;145
8147;Preferred;Basal cell adenocarcinoma;epithelial;Adenocarcinoma;147
8150;Preferred;Pancreatic neuroendocrine tumor nonfunctioning;neuroectodermal;Neuroendocrine tumor;150
8151;Preferred;Insulinoma;neuroectodermal;Neuroendocrine tumor;151
8152;Preferred;Glucagonoma;neuroectodermal;Neuroendocrine tumor;152
8153;Preferred;Gastrinoma;neuroectodermal;Neuroendocrine tumor;153
8154;Preferred;Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN);neuroectodermal;Neuroendocrine tumor;154
8155;Preferred;Vipoma;neuroectodermal;Neuroendocrine tumor;155
8156;Preferred;Somatostatinoma;neuroectodermal;Neuroendocrine tumor;156
8158;Preferred;ACTH-producing tumor;neuroectodermal;Neuroendocrine tumor;158
8160;Preferred;Cholangiocarcinoma;epithelial;Adenocarcinoma;160
8161;Preferred;Bile duct cystadenocarcinoma;epithelial;Adenocarcinoma;161
8162;Preferred;Klatskin tumor;epithelial;Adenocarcinoma;162
8163;Preferred;Pancreatobiliary type carcinoma;epithelial;Adenocarcinoma;163
8170;Preferred;Hepatocellular carcinoma;epithelial;Hepatocellular carcinoma;170
8171;Preferred;Hepatocellular carcinoma fibrolamellar;epithelial;Hepatocellular carcinoma;171
8172;Preferred;Hepatocellular carcinoma scirrhous;epithelial;Hepatocellular carcinoma;172
8173;Preferred;Hepatocellular carcinoma spindle cell variant;epithelial;Hepatocellular carcinoma;173
8174;Preferred;Hepatocellular carcinoma clear cell type;epithelial;Hepatocellular carcinoma;174
8175;Preferred;Hepatocellular carcinoma pleomorphic type;epithelial;Hepatocellular carcinoma;175
8180;Preferred;Combined hepatocellular carcinoma and cholangiocarcinoma;epithelial;Combined hepatocellular carcinoma and cholangiocarcinoma;180
8190;Preferred;Trabecular adenocarcinoma;epithelial;Adenocarcinoma;190
8200;Preferred;Adenoid cystic carcinoma;epithelial;Adenoid cystic carcinoma;200
8201;Preferred;Cribriform carcinoma;epithelial;Adenocarcinoma;201
8210;Preferred;Adenocarcinoma in adenomatous polyp;epithelial;Adenocarcinoma;210
8211;Preferred;Tubular adenocarcinoma;epithelial;Adenocarcinoma;211
8213;Preferred;Serrated adenocarcinoma;epithelial;Adenocarcinoma;213
8214;Preferred;Parietal cell carcinoma;epithelial;Adenocarcinoma;214
8215;Preferred;Adenocarcinoma of anal glands;epithelial;Adenocarcinoma;215
8220;Preferred;Adenocarcinoma in adenomatous polyposis coli;epithelial;Adenocarcinoma;220
8221;Preferred;Adenocarcinoma in multiple adenomatous polyps;epithelial;Adenocarcinoma;221
8230;Preferred;Solid carcinoma;epithelial;Carcinoma;230
8231;Preferred;Carcinoma simplex;epithelial;Carcinoma;231
8240;Preferred;Neuroendocrine tumor;neuroectodermal;Neuroendocrine tumor;240
8241;Preferred;Enterochromaffin cell carcinoid;neuroectodermal;Neuroendocrine tumor;241
8242;Preferred;Enterochromaffin-like cell tumormalignant;neuroectodermal;Neuroendocrine tumor;242
8243;Preferred;Goblet cell carcinoid;mixed or multipotent stem cell;Goblet cell carcinoid;243
8244;Preferred;Mixed adenoneuroendocrine carcinoma;mixed or multipotent stem cell;Neuroendocrine tumor;244
8245;Preferred;Adenocarcinoid tumor;mixed or multipotent stem cell;Neuroendocrine tumor;245
8246;Preferred;Neuroendocrine carcinoma;epithelial;Neuroendocrine tumor;246
8247;Preferred;Merkel cell carcinoma;epithelial;Merkel cell carcinoma;247
8249;Preferred;Neuroendocrine tumor grade 2;neuroectodermal;Neuroendocrine tumor;249
8250;Preferred;Lepidic adenocarcinoma;epithelial;Adenocarcinoma;250
8251;Preferred;Alveolar adenocarcinoma;epithelial;Adenocarcinoma;251
8252;Preferred;Bronchiolo-alveolar carcinoma non-mucinous;epithelial;Adenocarcinoma;252
8253;Preferred;Adenocarcinoma of the lung mucinous;epithelial;Adenocarcinoma;253
8254;Preferred;Adenocarcinoma of the lung mixed mucinous and non-mucinous;epithelial;Adenocarcinoma;254
8255;Preferred;Adenocarcinoma with mixed subtypes;epithelial;Adenocarcinoma;255
8256;Preferred;Minimally invasive adenocarcinoma non-mucinous;epithelial;Adenocarcinoma;256
8257;Preferred;Minimally invasive adenocarcinoma mucinous;epithelial;Adenocarcinoma;257
8260;Preferred;Papillary adenocarcinoma;epithelial;Adenocarcinoma;260
8261;Preferred;Adenocarcinoma in villous adenoma;epithelial;Adenocarcinoma;261
8262;Preferred;Villous adenocarcinoma;epithelial;Adenocarcinoma;262
8263;Preferred;Adenocarcinoma in tubulovillous adenoma;epithelial;Adenocarcinoma;263
8265;Preferred;Micropapillary carcinoma;epithelial;Adenocarcinoma;265
8270;Preferred;Chromophobe carcinoma;epithelial;Adenocarcinoma;270
8272;Preferred;Pituitary carcinoma;epithelial;Pituitary carcinoma;272
8273;Preferred;Pituitary blastoma;mixed or multipotent stem cell;Pituitary blastoma;273
8280;Preferred;Acidophil carcinoma;epithelial;Carcinoma;280
8281;Preferred;Mixed acidophil-basophil carcinoma;epithelial;Carcinoma;281
8290;Preferred;Oxyphilic adenocarcinoma;epithelial;Adenocarcinoma;290
8300;Preferred;Basophil carcinoma;epithelial;Carcinoma;300
8310;Preferred;Clear cell adenocarcinoma;epithelial;Adenocarcinoma;310
8311;Preferred;HRCC-associated renal cell carcinoma;epithelial;Adenocarcinoma;311
8312;Preferred;Renal cell carcinoma;epithelial;Adenocarcinoma;312
8313;Preferred;Clear cell adenocarcinofibroma;epithelial;Adenocarcinoma;313
8314;Preferred;Lipid-rich carcinoma;epithelial;Carcinoma;314
8315;Preferred;Glycogen-rich carcinoma;epithelial;Carcinoma;315
8316;Preferred;Cyst-associated renal cell carcinoma;epithelial;Adenocarcinoma;316
8317;Preferred;Renal cell carcinoma chromophobe type;epithelial;Adenocarcinoma;317
8318;Preferred;Renal cell carcinoma sarcomatoid;epithelial;Adenocarcinoma;318
8319;Preferred;Collecting duct carcinoma;epithelial;Adenocarcinoma;319
8320;Preferred;Granular cell carcinoma;mesenchymal;Granular cell carcinoma;320
8322;Preferred;Water-clear cell adenocarcinoma;epithelial;Adenocarcinoma;322
8323;Preferred;Mixed cell adenocarcinoma;epithelial;Adenocarcinoma;323
8330;Preferred;Follicular carcinoma;epithelial;Adenocarcinoma;330
8331;Preferred;Follicular adenocarcinoma well differentiated;epithelial;Adenocarcinoma;331
8332;Preferred;Follicular adenocarcinoma trabecular;epithelial;Adenocarcinoma;332
8333;Preferred;Fetal adenocarcinoma;epithelial;Adenocarcinoma;333
8335;Preferred;Follicular carcinoma minimally invasive;epithelial;Adenocarcinoma;335
8337;Preferred;Poorly differentiated thyroid carcinoma;epithelial;Adenocarcinoma;337
8339;Preferred;Follicular carcinoma encapsulated angioinvasive;epithelial;Adenocarcinoma;339
8340;Preferred;Papillary carcinoma follicular variant;epithelial;Adenocarcinoma;340
8341;Preferred;Papillary microcarcinoma;epithelial;Adenocarcinoma;341
8342;Preferred;Papillary carcinoma oncocytic variant;epithelial;Adenocarcinoma;342
8343;Preferred;Papillary carcinoma encapsulated of thyroid;epithelial;Adenocarcinoma;343
8344;Preferred;Papillary carcinoma columnar cell;epithelial;Adenocarcinoma;344
8345;Preferred;Medullary thyroid carcinoma;neuroectodermal;Medullary thyroid carcinoma;345
8346;Preferred;Mixed medullary-follicular carcinoma;mixed or multipotent stem cell;Carcinoma;346
8347;Preferred;Mixed medullary-papillary carcinoma;mixed or multipotent stem cell;Carcinoma;347
8350;Preferred;Nonencapsulated sclerosing carcinoma;epithelial;Carcinoma;350
8370;Preferred;Adrenal cortical carcinoma;epithelial;Adrenal cortical carcinoma;370
8380;Preferred;Endometrioid adenocarcinoma;epithelial;Adenocarcinoma;380
8381;Preferred;Endometrioid adenofibroma malignant;epithelial;Adenocarcinoma;381
8382;Preferred;Endometrioid adenocarcinoma secretory variant;epithelial;Adenocarcinoma;382
8383;Preferred;Endometrioid adenocarcinoma ciliated cell variant;epithelial;Adenocarcinoma;383
8384;Preferred;Adenocarcinoma endocervical type;epithelial;Adenocarcinoma;384
8390;Preferred;Adnexal adenocarcinoma;epithelial;Adenocarcinoma;390
8400;Preferred;Sweat gland adenocarcinoma;epithelial;Adenocarcinoma;400
8401;Preferred;Apocrine adenocarcinoma;epithelial;Adenocarcinoma;401
8402;Preferred;Hidradenocarcinoma;epithelial;Adenocarcinoma;402
8403;Preferred;Malignant eccrine spiradenoma;epithelial;Adenocarcinoma;403
8406;Preferred;Syringocystadenocarcinoma papilliferum;epithelial;Adenocarcinoma;406
8407;Preferred;Microcystic adnexal carcinoma;epithelial;Adenocarcinoma;407
8408;Preferred;Digital papillary adenocarcinoma;epithelial;Adenocarcinoma;408
8409;Preferred;Porocarcinoma;epithelial;Adenocarcinoma;409
8410;Preferred;Sebaceous carcinoma;epithelial;Adenocarcinoma;410
8413;Preferred;Eccrine adenocarcinoma;epithelial;Adenocarcinoma;413
8420;Preferred;Ceruminous adenocarcinoma;epithelial;Adenocarcinoma;420
8430;Preferred;Mucoepidermoid carcinoma;epithelial;Adenocarcinoma;430
8440;Preferred;Cystadenocarcinoma;epithelial;Adenocarcinoma;440
8441;Preferred;Serous carcinoma;epithelial;Adenocarcinoma;441
8450;Preferred;Papillary cystadenocarcinoma;epithelial;Adenocarcinoma;450
8452;Preferred;Solid pseudopapillary neoplasm of the pancreas;mixed or multipotent stem cell;Solid pseudopapillary neoplasm of the pancreas;452
8453;Preferred;IPMN with an associated invasive carcinoma;epithelial;Adenocarcinoma;453
8460;Preferred;Low grade serous carcinoma;epithelial;Adenocarcinoma;460
8461;Preferred;High grade serous carcinoma;epithelial;Adenocarcinoma;461
8470;Preferred;Mucinous cystadenocarcinoma;epithelial;Adenocarcinoma;470
8474;Preferred;Seromucinous carcinoma;epithelial;Adenocarcinoma;474
8480;Preferred;Mucinous adenocarcinoma;epithelial;Adenocarcinoma;480
8481;Preferred;Mucin-producing adenocarcinoma;epithelial;Adenocarcinoma;481
8482;Preferred;Mucinous carcinoma gastric type;epithelial;Adenocarcinoma;482
8490;Preferred;Signet ring cell carcinoma;epithelial;Adenocarcinoma;490
8500;Preferred;Infiltrating duct carcinoma;epithelial;Adenocarcinoma;500
8501;Preferred;Comedocarcinoma;epithelial;Adenocarcinoma;501
8502;Preferred;Secretory carcinoma;epithelial;Adenocarcinoma;502
8503;Preferred;Intraductal papillary adenocarcinoma with invasion;epithelial;Adenocarcinoma;503
8504;Preferred;Encapsulated papillary carcinoma with invasion;epithelial;Adenocarcinoma;504
8507;Preferred;Invasive micropapillary carcinoma of breast;epithelial;Adenocarcinoma;507
8508;Preferred;Cystic hypersecretory carcinoma;epithelial;Adenocarcinoma;508
8509;Preferred;Solid papillary carcinoma with invasion;epithelial;Adenocarcinoma;509
8510;Preferred;Medullary carcinoma;epithelial;Carcinoma;510
8512;Preferred;Medullary carcinoma with lymphoid stroma;epithelial;Carcinoma;512
8513;Preferred;Atypical medullary carcinoma;epithelial;Carcinoma;513
8514;Preferred;Duct carcinoma desmoplastic type;epithelial;Adenocarcinoma;514
8520;Preferred;Lobular carcinoma;epithelial;Adenocarcinoma;520
8521;Preferred;Infiltrating ductular carcinoma;epithelial;Adenocarcinoma;521
8522;Preferred;Infiltrating duct and lobular carcinoma;epithelial;Adenocarcinoma;522
8523;Preferred;Infiltrating duct mixed with other types of carcinoma;epithelial;Adenocarcinoma;523
8524;Preferred;Infiltrating lobular mixed with other types of carcinoma;epithelial;Adenocarcinoma;524
8525;Preferred;Polymorphous adenocarcinoma;epithelial;Adenocarcinoma;525
8530;Preferred;Inflammatory carcinoma;epithelial;Adenocarcinoma;530
8540;Preferred;Paget disease mammary;epithelial;Adenocarcinoma;540
8541;Preferred;Paget disease and infiltrating duct carcinoma of breast;epithelial;Adenocarcinoma;541
8542;Preferred;Paget disease extramammary;epithelial;Adenocarcinoma;542
8543;Preferred;Paget disease and intraductal carcinoma of breast;epithelial;Adenocarcinoma;543
8550;Preferred;Acinar cell carcinoma;epithelial;Adenocarcinoma;550
8551;Preferred;Acinar cell cystadenocarcinoma;epithelial;Adenocarcinoma;551
8552;Preferred;Mixed acinar-ductal carcinoma;epithelial;Adenocarcinoma;552
8560;Preferred;Adenosquamous carcinoma;epithelial;Carcinoma;560
8562;Preferred;Epithelial-myoepithelial carcinoma;mixed or multipotent stem cell;Epithelial-myoepithelial carcinoma;562
8570;Preferred;Adenocarcinoma with squamous metaplasia;epithelial;Adenocarcinoma;570
8571;Preferred;Adenocarcinoma with cartilaginous and osseous metaplasia;epithelial;Adenocarcinoma;571
8572;Preferred;Adenocarcinoma with spindle cell metaplasia;epithelial;Adenocarcinoma;572
8573;Preferred;Adenocarcinoma with apocrine metaplasia;epithelial;Adenocarcinoma;573
8574;Preferred;Adenocarcinoma with neuroendocrine differentiation;epithelial;Adenocarcinoma;574
8575;Preferred;Metaplastic carcinoma;epithelial;Carcinoma;575
8576;Preferred;Hepatoid adenocarcinoma;epithelial;Adenocarcinoma;576
8580;Preferred;Thymoma;epithelial;Thymoma;580
8581;Preferred;Thymoma type A;epithelial;Thymoma;581
8582;Preferred;Thymoma type AB;epithelial;Thymoma;582
8583;Preferred;Thymoma type B1;epithelial;Thymoma;583
8584;Preferred;Thymoma type B2;epithelial;Thymoma;584
8585;Preferred;Thymoma type B3;epithelial;Thymoma;585
8586;Preferred;Thymic carcinoma;epithelial;Thymic carcinoma;586
8588;Preferred;Spindle epithelial tumor with thymus-like element;epithelial;Carcinoma;588
8589;Preferred;Intrathyroid thymic carcinoma;epithelial;Thymic carcinoma;589
8600;Preferred;Thecoma malignant;germ cell;germ cell tumor;600
8620;Preferred;Adult granulosa cell tumor of ovary;germ cell;germ cell tumor;620
8630;Preferred;Androblastomamalignant;germ cell;germ cell tumor;630
8631;Preferred;Sertoli-Leydig cell tumor;germ cell;Sertoli-Leydig cell tumor;631
8634;Preferred;Sertoli-Leydig cell tumor;germ cell;Sertoli-Leydig cell tumor;634
8640;Preferred;Sertoli cell carcinoma;germ cell;Sertoli cell carcinoma;640
8650;Preferred;Leydig cell tumor malignant;germ cell;Leydig cell tumor malignant;650
8670;Preferred;Steroid cell tumor malignant;germ cell;Steroid cell tumor malignant;670
8680;Preferred;Paraganglioma;neuroectodermal;Paraganglioma;680
8681;Preferred;Sympathetic paraganglioma;neuroectodermal;Paraganglioma;681
8682;Preferred;Parasympathetic paraganglioma;neuroectodermal;Paraganglioma;682
8690;Preferred;Middle ear paraganglioma;neuroectodermal;Paraganglioma;690
8691;Preferred;Aortic body tumor;neuroectodermal;Paraganglioma;691
8692;Preferred;Carotid body paraganglioma;neuroectodermal;Paraganglioma;692
8693;Preferred;Extra-adrenal paraganglioma;neuroectodermal;Paraganglioma;693
8700;Preferred;Pheochromocytoma;neuroectodermal;Pheochromocytoma;700
8710;Preferred;Glomangiosarcoma;mesenchymal;Glomangiosarcoma;710
8711;Preferred;Glomus tumormalignant;mesenchymal;Paraganglioma;711
8714;Preferred;Perivascular epithelioid tumor malignant;mesenchymal;PEComa;714
8720;Preferred;Malignant melanoma;neuroectodermal;Melanoma;720
8721;Preferred;Nodular melanoma;neuroectodermal;Melanoma;721
8722;Preferred;Balloon cell melanoma;neuroectodermal;Melanoma;722
8723;Preferred;Malignant melanoma regressing;neuroectodermal;Melanoma;723
8728;Preferred;Meningeal melanomatosis;neuroectodermal;Melanoma;728
8730;Preferred;Amelanotic melanoma;neuroectodermal;Melanoma;730
8740;Preferred;Malignant melanoma in junctional nevus;neuroectodermal;Melanoma;740
8741;Preferred;Malignant melanoma in precancerous melanosis;neuroectodermal;Melanoma;741
8742;Preferred;Lentigo maligna melanoma;neuroectodermal;Melanoma;742
8743;Preferred;Low cumulative sun damage melanoma;neuroectodermal;Melanoma;743
8744;Preferred;Acral melanoma;neuroectodermal;Melanoma;744
8745;Preferred;Desmoplastic melanoma;neuroectodermal;Melanoma;745
8746;Preferred;Mucosal lentiginous melanoma;neuroectodermal;Melanoma;746
8761;Preferred;Malignant melanoma arising in giant congenital nevus;neuroectodermal;Melanoma;761
8770;Preferred;Malignant Spitz tumor;neuroectodermal;Melanoma;770
8771;Preferred;Epithelioid cell melanoma;neuroectodermal;Melanoma;771
8772;Preferred;Spindle cell melanoma;neuroectodermal;Melanoma;772
8773;Preferred;Spindle cell melanoma type A;neuroectodermal;Melanoma;773
8774;Preferred;Spindle cell melanoma type B;neuroectodermal;Melanoma;774
8780;Preferred;Blue nevus malignant;neuroectodermal;Melanoma;780
8800;Preferred;Sarcoma;mesenchymal;Sarcoma;800
8801;Preferred;Spindle cell sarcoma;mesenchymal;Sarcoma;801
8802;Preferred;Giant cell sarcoma;mesenchymal;Sarcoma;802
8803;Preferred;Small cell sarcoma;mesenchymal;Small cell sarcoma;803
8804;Preferred;Epithelioid sarcoma;mesenchymal;Sarcoma;804
8805;Preferred;Undifferentiated sarcoma;mesenchymal;Undifferentiated sarcoma;805
8806;Preferred;Desmoplastic small round cell tumor;mesenchymal;Desmoplastic small round cell tumor;806
8810;Preferred;Fibrosarcoma;mesenchymal;Fibrosarcoma;810
8811;Preferred;Myxofibrosarcoma;mesenchymal;Myxofibrosarcoma;811
8812;Preferred;Periosteal fibrosarcoma;mesenchymal;Fibrosarcoma;812
8813;Preferred;Fascial fibrosarcoma;mesenchymal;Fibrosarcoma;813
8814;Preferred;Infantile fibrosarcoma;mesenchymal;Fibrosarcoma;814
8815;Preferred;Solitary fibrous tumormalignant;mesenchymal;Solitary fibrous tumor;815
8825;Preferred;Myofibroblastic sarcoma;mesenchymal;Myofibroblastic sarcoma;825
8830;Preferred;Malignant fibrous histiocytoma;mesenchymal;Sarcoma;830
8832;Preferred;Dermatofibrosarcoma protuberans fibrosarcomatous;mesenchymal;Dermatofibrosarcoma protuberans;832
8840;Preferred;Myxosarcoma;mesenchymal;Myxosarcoma;840
8842;Preferred;Ossifying fibromyxoid tumormalignant;mesenchymal;Ossifying fibromyxoid tumor;842
8850;Preferred;Liposarcoma;mesenchymal;Liposarcoma;850
8851;Preferred;Liposarcoma well differentiated;mesenchymal;Liposarcoma;851
8852;Preferred;Myxoid liposarcoma;mesenchymal;Myxoid liposarcoma;852
8853;Preferred;Round cell liposarcoma;mesenchymal;Liposarcoma;853
8854;Preferred;Pleomorphic liposarcoma;mesenchymal;Liposarcoma;854
8855;Preferred;Mixed liposarcoma;mesenchymal;Liposarcoma;855
8857;Preferred;Fibroblastic liposarcoma;mesenchymal;Liposarcoma;857
8858;Preferred;Dedifferentiated liposarcoma;mesenchymal;Dedifferentiated liposarcoma;858
8890;Preferred;Leiomyosarcoma;mesenchymal;Leiomyosarcoma;890
8891;Preferred;Epithelioid leiomyosarcoma;mesenchymal;Leiomyosarcoma;891
8894;Preferred;Angiomyosarcoma;mesenchymal;Angiomyosarcoma;894
8895;Preferred;Myosarcoma;mesenchymal;Sarcoma;895
8896;Preferred;Myxoid leiomyosarcoma;mesenchymal;Leiomyosarcoma;896
8900;Preferred;Rhabdomyosarcoma;mesenchymal;Rhabdomyosarcoma;900
8901;Preferred;Pleomorphic rhabdomyosarcoma adult type;mesenchymal;Rhabdomyosarcoma;901
8902;Preferred;Mixed type rhabdomyosarcoma;mesenchymal;Rhabdomyosarcoma;902
8910;Preferred;Embryonal rhabdomyosarcoma;mesenchymal;Rhabdomyosarcoma;910
8912;Preferred;Spindle cell rhabdomyosarcoma;mesenchymal;Rhabdomyosarcoma;912
8920;Preferred;Alveolar rhabdomyosarcoma;mesenchymal;Rhabdomyosarcoma;920
8921;Preferred;Ectomesenchymoma;mixed or multipotent stem cell;Ectomesenchymoma;921
8930;Preferred;Endometrial stromal sarcoma;mesenchymal;Endometrial stromal sarcoma;930
8931;Preferred;Endometrial stromal sarcoma low grade;mesenchymal;Endometrial stromal sarcoma;931
8933;Preferred;Adenosarcoma;mesenchymal;Adenosarcoma;933
8934;Preferred;Carcinofibroma;mesenchymal;Carcinofibroma;934
8935;Preferred;Stromal sarcoma;mesenchymal;Sarcoma;935
8936;Preferred;Gastrointestinal stromal tumor;mesenchymal;Gastrointestinal stromal tumor;936
8940;Preferred;Mixed tumor;mixed or multipotent stem cell;Neoplasm;940
8941;Preferred;Carcinoma ex pleomorphic adenoma;epithelial;Adenocarcinoma;941
8950;Preferred;Mullerian mixed tumor;mixed or multipotent stem cell;Mullerian mixed tumor;950
8951;Preferred;Mesodermal mixed tumor;mixed or multipotent stem cell;Mesodermal mixed tumor;951
8959;Preferred;Malignant cystic nephroma;mixed or multipotent stem cell;Malignant cystic nephroma;959
8960;Preferred;Nephroblastoma;mixed or multipotent stem cell;Nephroblastoma;960
8963;Preferred;Rhabdoid tumor;mixed or multipotent stem cell;Rhabdoid tumor;963
8964;Preferred;Clear cell sarcoma of kidney;mixed or multipotent stem cell;Sarcoma;964
8970;Preferred;Hepatoblastoma;mixed or multipotent stem cell;Hepatoblastoma;970
8971;Preferred;Pancreatoblastoma;mixed or multipotent stem cell;Pancreatoblastoma;971
8972;Preferred;Pulmonary blastoma;mixed or multipotent stem cell;Pulmonary blastoma;972
8973;Preferred;Pleuropulmonary blastoma;mixed or multipotent stem cell;Pleuropulmonary blastoma;973
8980;Preferred;Carcinosarcoma;mixed or multipotent stem cell;Carcinosarcoma;980
8981;Preferred;Carcinosarcoma;mixed or multipotent stem cell;Carcinosarcoma;981
8982;Preferred;Myoepithelial carcinoma;mixed or multipotent stem cell;Myoepithelial carcinoma;982
8983;Preferred;Adenomyoepithelioma with carcinoma;mixed or multipotent stem cell;Adenomyoepithelioma with carcinoma;983
8990;Preferred;Mesenchymoma;mixed or multipotent stem cell;Mesenchymoma;990
8991;Preferred;Embryonal sarcoma;mesenchymal;Embryonal sarcoma;991
9000;Preferred;Brenner tumor malignant;epithelial;malignant Brenner tumor;1000
9014;Preferred;Serous adenocarcinofibroma;epithelial;Serous adenocarcinofibroma;1014
9015;Preferred;Mucinous adenocarcinofibroma;epithelial;Mucinous adenocarcinofibroma;1015
9020;Preferred;Phyllodes tumor;mixed or multipotent stem cell;Phyllodes tumor;1020
9040;Preferred;Synovial sarcoma;mesenchymal;Synovial sarcoma;1040
9041;Preferred;Synovial sarcoma spindle cell;mesenchymal;Synovial sarcoma;1041
9042;Preferred;Synovial sarcoma epithelioid cell;mesenchymal;Synovial sarcoma;1042
9043;Preferred;Synovial sarcoma biphasic;mesenchymal;Synovial sarcoma;1043
9044;Preferred;Clear cell sarcoma;mesenchymal;Clear cell sarcoma;1044
9045;Preferred;Biphenotypic sinonasal sarcoma;mesenchymal;Biphenotypic sinonasal sarcoma;1045
9050;Preferred;Mesotheliomamalignant;mesenchymal;Mesothelioma;1050
9051;Preferred;Fibrous mesothelioma;mesenchymal;Mesothelioma;1051
9052;Preferred;Epithelioid mesothelioma;mesenchymal;Mesothelioma;1052
9053;Preferred;Mesothelioma biphasic;mesenchymal;Mesothelioma;1053
9060;Preferred;Dysgerminoma;germ cell;Dysgerminoma;1060
9061;Preferred;Seminoma;germ cell;Seminoma;1061
9062;Preferred;Seminoma anaplastic;germ cell;Seminoma anaplastic;1062
9063;Preferred;Spermatocytic seminoma;germ cell;Spermatocytic seminoma;1063
9064;Preferred;Germinoma;germ cell;Germinoma;1064
9065;Preferred;Germ cell tumor nonseminomatous;germ cell;Germ cell tumor nonseminomatous;1065
9070;Preferred;Embryonal carcinoma;germ cell;Embryonal carcinoma;1070
9071;Preferred;Yolk sac tumor;germ cell;Yolk sac tumor;1071
9072;Preferred;Polyembryoma;germ cell;Polyembryoma;1072
9080;Preferred;Teratoma;mixed or multipotent stem cell;Teratoma;1080
9081;Preferred;Teratocarcinoma;mixed or multipotent stem cell;Teratocarcinoma;1081
9082;Preferred;Malignant teratoma undifferentiated;mixed or multipotent stem cell;Teratoma;1082
9083;Preferred;Malignant teratoma intermediate;mixed or multipotent stem cell;Teratoma;1083
9084;Preferred;Teratoma with malignant transformation;mixed or multipotent stem cell;Teratoma;1084
9085;Preferred;Mixed germ cell tumor;germ cell;Mixed germ cell tumor;1085
9086;Preferred;Germ cell tumor with associated hematological malignancy;germ cell;Germ cell tumor with associated hematological malignancy;1086
9090;Preferred;Struma ovariimalignant;epithelial;Adenocarcinoma;1090
9100;Preferred;Choriocarcinoma;germ cell;Choriocarcinoma;1100
9101;Preferred;Choriocarcinoma combined with other germ cell elements;germ cell;Choriocarcinoma;1101
9102;Preferred;Malignant teratoma trophoblastic;mixed or multipotent stem cell;Teratoma;1102
9105;Preferred;Trophoblastic tumor epithelioid;germ cell;Trophoblastic tumor;1105
9110;Preferred;Mesonephroma;germ cell;Mesonephroma;1110
9120;Preferred;Hemangiosarcoma;mesenchymal;Hemangiosarcoma;1120
9124;Preferred;Kupffer cell sarcoma;mesenchymal;Kupffer cell sarcoma;1124
9130;Preferred;Hemangioendothelioma;mesenchymal;Hemangioendothelioma;1130
9133;Preferred;Epithelioid hemangioendothelioma;mesenchymal;Epithelioid hemangioendothelioma;1133
9137;Preferred;Intimal sarcoma;mesenchymal;Intimal sarcoma;1137
9140;Preferred;Kaposi sarcoma;mesenchymal;Kaposi sarcoma;1140
9170;Preferred;Lymphangiosarcoma;mesenchymal;Lymphangiosarcoma;1170
9180;Preferred;Osteosarcoma;mesenchymal;Osteosarcoma;1180
9181;Preferred;Chondroblastic osteosarcoma;mesenchymal;Osteosarcoma;1181
9182;Preferred;Fibroblastic osteosarcoma;mesenchymal;Osteosarcoma;1182
9183;Preferred;Telangiectatic osteosarcoma;mesenchymal;Osteosarcoma;1183
9184;Preferred;Osteosarcoma in Paget disease of bone;mesenchymal;Osteosarcoma;1184
9185;Preferred;Small cell osteosarcoma;mesenchymal;Osteosarcoma;1185
9186;Preferred;Central osteosarcoma;mesenchymal;Osteosarcoma;1186
9187;Preferred;Low grade central osteosarcoma;mesenchymal;Osteosarcoma;1187
9192;Preferred;Parosteal osteosarcoma;mesenchymal;Osteosarcoma;1192
9193;Preferred;Periosteal osteosarcoma;mesenchymal;Osteosarcoma;1193
9194;Preferred;High grade surface osteosarcoma;mesenchymal;Osteosarcoma;1194
9195;Preferred;Intracortical osteosarcoma;mesenchymal;Osteosarcoma;1195
9220;Preferred;Chondrosarcoma;mesenchymal;Chondrosarcoma;1220
9221;Preferred;Periosteal chondrosarcoma;mesenchymal;Chondrosarcoma;1221
9230;Preferred;Chondroblastoma;mesenchymal;Chondroblastoma;1230
9231;Preferred;Myxoid chondrosarcoma;mesenchymal;Myxoid chondrosarcoma;1231
9240;Preferred;Mesenchymal chondrosarcoma;mesenchymal;Chondrosarcoma;1240
9242;Preferred;Clear cell chondrosarcoma;mesenchymal;Chondrosarcoma;1242
9243;Preferred;Dedifferentiated chondrosarcoma;mesenchymal;Chondrosarcoma;1243
9250;Preferred;Giant cell tumor of bone malignant;mesenchymal;malignant giant cell tumor of bone;1250
9251;Preferred;Malignant giant cell tumor of soft parts;mesenchymal;Malignant giant cell tumor of soft parts;1251
9252;Preferred;Malignant tenosynovial giant cell tumor;mesenchymal;Malignant tenosynovial giant cell tumor;1252
9261;Preferred;Adamantinoma of long bones;epithelial;Adamantinoma of long bones;1261
9270;Preferred;Odontogenic tumor;epithelial;Odontogenic tumor;1270
9290;Preferred;Ameloblastic odontosarcoma;epithelial;Ameloblastic odontosarcoma;1290
9302;Preferred;Ghost cell odontogenic carcinoma ;epithelial;Ghost cell odontogenic carcinoma;1302
9310;Preferred;Ameloblastoma metastasizing;epithelial;Ameloblastoma;1310
9330;Preferred;Ameloblastic fibrosarcoma;epithelial;Ameloblastic fibrosarcoma;1330
9341;Preferred;Clear cell odontogenic carcinoma;epithelial;Clear cell odontogenic carcinoma;1341
9342;Preferred;Odontogenic carcinosarcoma ;mixed or multipotent stem cell;Odontogenic carcinosarcoma;1342
9362;Preferred;Pineoblastoma;mixed or multipotent stem cell;Pineoblastoma;1362
9364;Preferred;Ewing sarcoma;mesenchymal;Ewing sarcoma;1364
9365;Preferred;Askin tumor;neuroectodermal;Ewing sarcoma;1365
9370;Preferred;Chordoma;mixed or multipotent stem cell;Chordoma;1370
9371;Preferred;Chondroid chordoma;mixed or multipotent stem cell;Chordoma;1371
9372;Preferred;Dedifferentiated chordoma;mixed or multipotent stem cell;Chordoma;1372
9380;Preferred;Glioma malignant;neuroectodermal;Glioma;1380
9381;Preferred;Gliomatosis cerebri;neuroectodermal;Glioma;1381
9382;Preferred;Oligoastrocytoma;neuroectodermal;Oligoastrocytoma;1382
9385;Preferred;Diffuse midline glioma H3 K27M-mutant;neuroectodermal;Glioma;1385
9390;Preferred;Choroid plexus carcinoma;epithelial;Choroid plexus carcinoma;1390
9391;Preferred;Ependymoma;neuroectodermal;Ependymoma;1391
9392;Preferred;Ependymoma anaplastic;neuroectodermal;Ependymoma;1392
9393;Preferred;Papillary ependymoma;neuroectodermal;Ependymoma;1393
9395;Preferred;Papillary tumor of the pineal region;neuroectodermal;Ependymoma;1395
9396;Preferred;Ependymoma RELA fusion-positive;neuroectodermal;Ependymoma;1396
9400;Preferred;Astrocytoma;neuroectodermal;Astrocytoma;1400
9401;Preferred;Astrocytoma anaplastic;neuroectodermal;Astrocytoma;1401
9410;Preferred;Protoplasmic astrocytoma;neuroectodermal;Astrocytoma;1410
9411;Preferred;Gemistocytic astrocytoma;neuroectodermal;Astrocytoma;1411
9420;Preferred;Fibrillary astrocytoma;neuroectodermal;Astrocytoma;1420
9423;Preferred;Polar spongioblastoma;neuroectodermal;Astrocytoma;1423
9424;Preferred;Pleomorphic xanthoastrocytoma;neuroectodermal;Astrocytoma;1424
9425;Preferred;Pilomyxoid astrocytoma;neuroectodermal;Astrocytoma;1425
9430;Preferred;Astroblastoma;neuroectodermal;Astroblastoma;1430
9440;Preferred;Glioblastoma;neuroectodermal;Glioblastoma;1440
9441;Preferred;Giant cell glioblastoma;neuroectodermal;Glioblastoma;1441
9442;Preferred;Gliosarcoma;neuroectodermal;Glioblastoma;1442
9445;Preferred;Glioblastoma IDH-mutant;neuroectodermal;Glioblastoma;1445
9450;Preferred;Oligodendroglioma;neuroectodermal;Oligodendroglioma;1450
9451;Preferred;Oligodendroglioma anaplastic;neuroectodermal;Oligodendroglioma;1451
9460;Preferred;Oligodendroblastoma;neuroectodermal;Oligodendroblastoma;1460
9470;Preferred;Medulloblastoma;neuroectodermal;Medulloblastoma;1470
9471;Preferred;Desmoplastic nodular medulloblastoma;neuroectodermal;Medulloblastoma;1471
9472;Preferred;Medullomyoblastoma;neuroectodermal;Medullomyoblastoma;1472
9473;Preferred;CNS embryonal tumor;neuroectodermal;CNS embryonal tumor;1473
9474;Preferred;Large cell medulloblastoma;neuroectodermal;Medulloblastoma;1474
9475;Preferred;Medullobloastoma WNT-activated;neuroectodermal;Medulloblastoma;1475
9476;Preferred;Medulloblastoma SHH-activated and TP53-mutant;neuroectodermal;Medulloblastoma;1476
9477;Preferred;Medulloblastoma non-WNT/non-SHH;neuroectodermal;Medulloblastoma;1477
9478;Preferred;Embryonal tumor with multilayered rosettes with C19MC alteration;neuroectodermal;Medulloblastoma;1478
9480;Preferred;Cerebellar sarcoma ;mixed or multipotent stem cell;Cerebellar sarcoma ;1480
9490;Preferred;Ganglioneuroblastoma;neuroectodermal;Ganglioneuroblastoma;1490
9500;Preferred;Neuroblastoma;neuroectodermal;Neuroblastoma;1500
9501;Preferred;Medulloepithelioma ;neuroectodermal;Medulloepithelioma ;1501
9502;Preferred;Teratoid medulloepithelioma;neuroectodermal;Teratoid medulloepithelioma;1502
9503;Preferred;Neuroepithelioma ;neuroectodermal;Neuroepithelioma ;1503
9504;Preferred;Spongioneuroblastoma;neuroectodermal;Spongioneuroblastoma;1504
9505;Preferred;Ganglioglioma anaplastic;neuroectodermal;Ganglioglioma;1505
9508;Preferred;Atypical teratoid/rhabdoid tumor;neuroectodermal;Rhabdoid tumor;1508
9510;Preferred;Retinoblastoma;mixed or multipotent stem cell;Retinoblastoma;1510
9511;Preferred;Retinoblastoma differentiated;mixed or multipotent stem cell;Retinoblastoma;1511
9512;Preferred;Retinoblastomaundifferentiated;mixed or multipotent stem cell;Retinoblastoma;1512
9513;Preferred;Retinoblastoma diffuse;mixed or multipotent stem cell;Retinoblastoma;1513
9520;Preferred;Olfactory neurogenic tumor;neuroectodermal;Olfactory neurogenic tumor;1520
9521;Preferred;Olfactory neurocytoma;neuroectodermal;Olfactory neurogenic tumor;1521
9522;Preferred;Olfactory neuroblastoma;neuroectodermal;Olfactory neurogenic tumor;1522
9523;Preferred;Olfactory neuroepithelioma;neuroectodermal;Olfactory neurogenic tumor;1523
9530;Preferred;Meningiomamalignant;mesenchymal;Meningioma;1530
9538;Preferred;Papillary meningioma;mesenchymal;Meningioma;1538
9539;Preferred;Meningeal sarcomatosis;mesenchymal;Meningioma;1539
9540;Preferred;Malignant peripheral nerve sheath tumor;neuroectodermal;Malignant peripheral nerve sheath tumor;1540
9542;Preferred;Malignant peripheral nerve sheath tumor epithelioid;neuroectodermal;Malignant peripheral nerve sheath tumor;1542
9560;Preferred;Neurilemomamalignant;neuroectodermal;Malignant peripheral nerve sheath tumor;1560
9561;Preferred;Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation;neuroectodermal;Malignant peripheral nerve sheath tumor;1561
9571;Preferred;Perineuriomamalignant;neuroectodermal;Malignant peripheral nerve sheath tumor;1571
9580;Preferred;Granular cell tumor malignant;neuroectodermal;Granular cell tumor;1580
9581;Preferred;Alveolar soft part sarcoma;mixed or multipotent stem cell;Alveolar soft part sarcoma;1581
9590;Preferred;lymphoma;hematopoietic ;Lymphoma;1590
9591;Preferred;lymphoma non-Hodgkin;hematopoietic ;Lymphoma;1591
9596;Preferred;Composite Hodgkin and non-Hodgkin lymphoma;hematopoietic ;Lymphoma;1596
9597;Preferred;Primary cutaneous follicle centre lymphoma;hematopoietic ;Lymphoma;1597
9650;Preferred;Hodgkin lymphoma;hematopoietic ;Hodgkin lymphoma;1650
9651;Preferred;Hodgkin lymphoma lymphocyte-rich;hematopoietic ;Hodgkin lymphoma;1651
9652;Preferred;Hodgkin lymphoma mixed cellularity;hematopoietic ;Hodgkin lymphoma;1652
9653;Preferred;Hodgkin lymphoma lymphocyte depletion;hematopoietic ;Hodgkin lymphoma;1653
9654;Preferred;Hodgkin lymphoma lymphocyte depletion diffuse fibrosis;hematopoietic ;Hodgkin lymphoma;1654
9655;Preferred;Hodgkin lymphoma lymphocyte depletion reticular;hematopoietic ;Hodgkin lymphoma;1655
9659;Preferred;Hodgkin lymphoma nodular lymphocyte predominant;hematopoietic ;Hodgkin lymphoma;1659
9661;Preferred;Hodgkin granuloma;hematopoietic ;Hodgkin lymphoma;1661
9662;Preferred;Hodgkin sarcoma;hematopoietic ;Hodgkin lymphoma;1662
9663;Preferred;Hodgkin lymphoma nodular sclerosis;hematopoietic ;Hodgkin lymphoma;1663
9664;Preferred;Hodgkin lymphoma nodular sclerosis cellular phase;hematopoietic ;Hodgkin lymphoma;1664
9665;Preferred;Hodgkin lymphoma nodular sclerosis grade 1;hematopoietic ;Hodgkin lymphoma;1665
9667;Preferred;Hodgkin lymphoma nodular sclerosis grade 2;hematopoietic ;Hodgkin lymphoma;1667
9670;Preferred;lymphoma non-Hodgkin;hematopoietic ;lymphoma non-Hodgkin;1670
9671;Preferred;Lymphoplasmacytic lymphoma;hematopoietic ;Lymphoplasmacytic lymphoma;1671
9673;Preferred;Mantle cell lymphoma;hematopoietic ;Mantle cell lymphoma;1673
9675;Preferred;Malignant lymphoma mixed small and large cell diffuse;hematopoietic ;Lymphoma;1675
9678;Preferred;Primary effusion lymphoma;hematopoietic ;Lymphoma;1678
9679;Preferred;Mediastinal large B-cell lymphoma;hematopoietic ;B-cell lymphoma;1679
9680;Preferred;Diffuse large B-cell lymphoma;hematopoietic ;Diffuse large B-cell lymphoma;1680
9684;Preferred;Lymphoma large B-cell diffuse immunoblastic;hematopoietic ;Lymphoma;1684
9687;Preferred;Burkitt lymphoma;hematopoietic ;Burkitt lymphoma;1687
9688;Preferred;T-cell/histiocyte rich large B-cell lymphoma;hematopoietic ;B-cell lymphoma;1688
9689;Preferred;Splenic marginal zone B-cell lymphoma;hematopoietic ;B-cell lymphoma;1689
9690;Preferred;Follicular lymphoma;hematopoietic ;Follicular lymphoma;1690
9691;Preferred;Follicular lymphoma grade 1/2;hematopoietic ;Follicular lymphoma;1691
9695;Preferred;Follicular lymphoma grade 1/2;hematopoietic ;Follicular lymphoma;1695
9698;Preferred;Follicular lymphoma grade 3;hematopoietic ;Follicular lymphoma;1698
9699;Preferred;Marginal zone B-cell lymphoma;hematopoietic ;Marginal zone B-cell lymphoma;1699
9700;Preferred;Mycosis fungoides;hematopoietic ;T-cell lymphoma;1700
9701;Preferred;Sezary syndrome;hematopoietic ;T-cell lymphoma;1701
9702;Preferred;Mature T-cell lymphoma;hematopoietic ;T-cell lymphoma;1702
9705;Preferred;Angioimmunoblastic T-cell lymphoma;hematopoietic ;Angioimmunoblastic T-cell lymphoma;1705
9708;Preferred;Subcutaneous panniculitis-like T-cell lymphoma;hematopoietic ;T-cell lymphoma;1708
9709;Preferred;Cutaneous T-cell lymphoma;hematopoietic ;T-cell lymphoma;1709
9712;Preferred;Intravascular large B-cell lymphoma;hematopoietic ;B-cell lymphoma;1712
9714;Preferred;Anaplastic large cell lymphoma T-cell and Null-cell type;hematopoietic ;Anaplastic large cell lymphoma;1714
9715;Preferred;Anaplastic large cell lymphoma ALK negative;hematopoietic ;Anaplastic large cell lymphoma;1715
9716;Preferred;Hepatosplenic T-cell lymphoma;hematopoietic ;T-cell lymphoma;1716
9717;Preferred;Intestinal T-cell lymphoma;hematopoietic ;T-cell lymphoma;1717
9718;Preferred;Primary cutaneous anaplastic large cell lymphoma;hematopoietic ;Anaplastic large cell lymphoma;1718
9719;Preferred;NK/T-cell lymphoma nasal and nasal type;hematopoietic ;NK/T-cell lymphoma;1719
9724;Preferred;Systemic EBV positive T-cell lymphoproliferative disease of childhood;hematopoietic ;T-cell lymphoma;1724
9726;Preferred;Primary cutaneous gamma-delta T-cell lymphoma;hematopoietic ;T-cell lymphoma;1726
9727;Preferred;Precursor cell lymphoblastic lymphoma;hematopoietic ;Lymphoma;1727
9731;Preferred;Plasmacytoma;hematopoietic ;Plasmacytoma;1731
9732;Preferred;Plasma cell myeloma;hematopoietic ;Plasmacytoma;1732
9733;Preferred;Plasma cell leukemia;hematopoietic ;Plasmacytoma;1733
9734;Preferred;Plasmacytoma extramedullary;hematopoietic ;Plasmacytoma;1734
9735;Preferred;Plasmablastic lymphoma;hematopoietic ;Plasmacytoma;1735
9737;Preferred;ALK positive large B-cell lymphoma;hematopoietic ;B-cell lymphoma;1737
9738;Preferred;HHV8-positive diffuse large B-cell lymphoma;hematopoietic ;B-cell lymphoma;1738
9740;Preferred;Mast cell sarcoma;hematopoietic ;Lymphoma;1740
9741;Preferred;Malignant mastocytosis;hematopoietic ;Lymphoma;1741
9742;Preferred;Mast cell leukemia;hematopoietic ;Leukemia;1742
9749;Preferred;Erdheim-Chester disease;hematopoietic ;Lymphoma;1749
9750;Preferred;Malignant histiocytosis;hematopoietic ;histiocytic tumor;1750
9751;Preferred;Langerhans cell histiocytosis disseminated;hematopoietic ;Langerhans cell histiocytosis;1751
9755;Preferred;Histiocytic sarcoma;hematopoietic ;histiocytic tumor;1755
9756;Preferred;Langerhans cell sarcoma;hematopoietic ;Langerhans cell histiocytosis;1756
9757;Preferred;Interdigitating dendritic cell sarcoma;hematopoietic ;Lymphoma;1757
9758;Preferred;Follicular dendritic cell sarcoma;hematopoietic ;Lymphoma;1758
9759;Preferred;Fibroblastic reticular cell tumor;hematopoietic ;Lymphoma;1759
9760;Preferred;Immunoproliferative disease;hematopoietic ;Immunoproliferative disease;1760
9761;Preferred;Waldenstrom macroglobulinemia;hematopoietic ;Immunoproliferative disease;1761
9762;Preferred;Heavy chain disease;hematopoietic ;Immunoproliferative disease;1762
9764;Preferred;Immunoproliferative small intestinal disease;hematopoietic ;Immunoproliferative disease;1764
9766;Preferred;Lymphomatoid granulomatosis grade 3;hematopoietic ;Immunoproliferative disease;1766
9800;Preferred;Leukemia;hematopoietic ;Leukemia;1800
9801;Preferred;Acute leukemia;hematopoietic ;Leukemia;1801
9805;Preferred;Acute biphenotypic leukemia;hematopoietic ;Leukemia;1805
9806;Preferred;Mixed phenotype acute leukemia with t(9,22)(q34,q11.2),BCR-ABL1;hematopoietic ;Leukemia;1806
9807;Preferred;Mixed phenotype acute leukemia with t(v,11q23),MLL rearranged;hematopoietic ;Leukemia;1807
9808;Preferred;Mixed phenotype acute leukemia;hematopoietic ;Leukemia;1808
9809;Preferred;Mixed phenotype acute leukemia;hematopoietic ;Leukemia;1809
9811;Preferred;B lymphoblastic leukemia/lymphoma;hematopoietic ;Leukemia;1811
9812;Preferred;B lymphoblastic leukemia/lymphoma with t(9,22)(q34,q11.2),BCR-ABL1;hematopoietic ;Leukemia;1812
9813;Preferred;B lymphoblastic leukemia/lymphoma with t(v,11q23),MLL rearranged;hematopoietic ;Leukemia;1813
9814;Preferred;B lymphoblastic leukemia/lymphoma with t(12,21)(p13,q22),TEL-AML1(ETV6-RUNX1);hematopoietic ;Leukemia;1814
9815;Preferred;B lymphoblastic leukemia/lymphoma with hyperdiploidy;hematopoietic ;Leukemia;1815
9816;Preferred;B lymphoblastic leukemia/lymphoma with hypodiploidy(Hypodiploid ALL);hematopoietic ;Leukemia;1816
9817;Preferred;B lymphoblastic leukemia/lymphoma with t(5,14)(q31,q32),IL3-IGH;hematopoietic ;Leukemia;1817
9818;Preferred;B lymphoblastic leukemia/lymphoma with t(1,19)(q23,p13.3),E2A-PBX1(TCF3-PBX1);hematopoietic ;Leukemia;1818
9819;Preferred;B lymphoblastic leukemia/lymphoma;hematopoietic ;Leukemia;1819
9820;Preferred;Lymphoid leukemia;hematopoietic ;Leukemia;1820
9823;Preferred;B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma;hematopoietic ;Chronic lymphocytic leukemia;1823
9827;Preferred;Adult T-cell leukemia/lymphoma (HTLV-1 positive);hematopoietic ;Leukemia;1827
9831;Preferred;T-cell large granular lymphocytic leukemia;hematopoietic ;Leukemia;1831
9832;Preferred;Prolymphocytic leukemia;hematopoietic ;Leukemia;1832
9833;Preferred;Prolymphocytic leukemia;hematopoietic ;Leukemia;1833
9834;Preferred;Prolymphocytic leukemia;hematopoietic ;Leukemia;1834
9835;Preferred;Precursor cell lymphoblastic leukemia;hematopoietic ;Leukemia;1835
9837;Preferred;Precursor T-cell lymphoblastic leukemia;hematopoietic ;Leukemia;1837
9840;Preferred;Acute erythroid leukemia;hematopoietic ;Leukemia;1840
9860;Preferred;Myeloid leukemia;hematopoietic ;Myeloid leukemia;1860
9861;Preferred;Acute myeloid leukemia;hematopoietic ;Acute myeloid leukemia;1861
9863;Preferred;Chronic myeloid leukemia;hematopoietic ;Chronic myeloid leukemia;1863
9865;Preferred;Acute myeloid leukemia with t(6,9)(p23,q34),DEK-NUP214;hematopoietic ;Acute myeloid leukemia;1864
9866;Preferred;Acute promyelocytic leukemia, t(15,17)(q22,q11-12);hematopoietic ;Acute myeloid leukemia;1865
9867;Preferred;Acute myelomonocytic leukemia;hematopoietic ;Acute myeloid leukemia;1867
9869;Preferred;Acute myeloid leukemia with inv(3)(q21,q26.2) or t(3,3)(q21,q26.2);hematopoietic ;Acute myeloid leukemia;1868
9870;Preferred;Acute basophilic leukemia;hematopoietic ;Acute myeloid leukemia;1870
9871;Preferred;Acute myeloid leukemia with abnormal marrow eosinophils;hematopoietic ;Acute myeloid leukemia;1871
9872;Preferred;Acute myeloid leukemia;hematopoietic ;Acute myeloid leukemia;1872
9873;Preferred;Acute myeloid leukemia without maturation;hematopoietic ;Acute myeloid leukemia;1873
9874;Preferred;Acute myeloid leukemia with maturation;hematopoietic ;Acute myeloid leukemia;1874
9875;Preferred;Chronic myelogenous leukemia;hematopoietic ;Chronic myeloid leukemia;1875
9876;Preferred;Atypical chronic myeloid leukemia;hematopoietic ;Acute myeloid leukemia;1876
9877;Preferred;Acute myeloid leukemia with mutated NPM1;hematopoietic ;Acute myeloid leukemia;1877
9878;Preferred;Acute myeloid leukemia with biallelic mutation of CEBPA;hematopoietic ;Acute myeloid leukemia;1878
9879;Preferred;Acute myeloid leukemia with mutated RUNX1;hematopoietic ;Acute myeloid leukemia;1879
9891;Preferred;Acute monocytic leukemia;hematopoietic ;Acute myeloid leukemia;1891
9895;Preferred;Acute myeloid leukemia with myelodysplasia-related changes;hematopoietic ;Acute myeloid leukemia;1895
9896;Preferred;Acute myeloid leukemia, t(8,21)(q22,q22);hematopoietic ;Acute myeloid leukemia;1896
9897;Preferred;Acute myeloid leukemia;hematopoietic ;Acute myeloid leukemia;1897
9898;Preferred;Myeloid leukemia associated with Down syndrome;hematopoietic ;Acute myeloid leukemia;1898
9910;Preferred;Acute megakaryoblastic leukemia;hematopoietic ;Acute myeloid leukemia;1910
9911;Preferred;Acute myeloid leukemia (megakaryoblastic) with t(1,22)(p13,q13),RBM15-MKL1;hematopoietic ;Acute myeloid leukemia;1911
9912;Preferred;Acute myleoid leukemia with BCR-ABL1;hematopoietic ;Acute myeloid leukemia;1912
9920;Preferred;Therapy-related myeloid neoplasm;hematopoietic ;Acute myeloid leukemia;1920
9930;Preferred;Myeloid sarcoma;hematopoietic ;Myeloid sarcoma;1930
9931;Preferred;Acute panmyelosis with myelofibrosis;hematopoietic ;Acute myeloid leukemia;1931
9940;Preferred;Hairy cell leukemia;hematopoietic ;Hairy cell leukemia;1940
9945;Preferred;Chronic myelomonocytic leukemia;hematopoietic ;Leukemia;1945
9946;Preferred;Juvenile myelomonocytic leukemia;hematopoietic ;Leukemia;1946
9948;Preferred;Aggressive NK-cell leukemia;hematopoietic ;Aggressive NK-cell leukemia;1948
9950;Preferred;Polycythemia vera;hematopoietic ;Polycythemia vera;1950
9960;Preferred;Myeloproliferative neoplasm;hematopoietic ;Myeloproliferative neoplasm;1960
9961;Preferred;Primary myelofibrosis;hematopoietic ;Primary myelofibrosis;1961
9962;Preferred;Essential thrombocythemia;hematopoietic ;Essential thrombocythemia;1962
9963;Preferred;Chronic neutrophilic leukemia;hematopoietic ;Leukemia;1963
9964;Preferred;Chronic eosinophilic leukemia;hematopoietic ;Leukemia;1964
9965;Preferred;Myeloid or lymphoid neoplasm with PDGFRA rearrangement;hematopoietic ;Myeloid neoplasm;1965
9966;Preferred;Myeloid neoplasm with PDGFRB rearrangement;hematopoietic ;Myeloid neoplasm;1966
9967;Preferred;Myeloid or lymphoid neoplasm with FGFR1 abnormalities;hematopoietic ;Myeloid neoplasm;1967
9968;Preferred;Myeloid or lymphoid neoplasm with PCM1-JAK2;hematopoietic ;Myeloid neoplasm;1968
9975;Preferred;Myeloproliferative neoplasm;hematopoietic ;Myeloproliferative neoplasm;1975
9980;Preferred;Myelodysplastic syndrome with single lineage dysplasia;hematopoietic ;Myelodysplastic syndrome;1980
9982;Preferred;Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia;hematopoietic ;Myelodysplastic syndrome;1982
9983;Preferred;Myelodysplastic syndrome with excess blasts;hematopoietic ;Myelodysplastic syndrome;1983
9984;Preferred;Refractory anemia with excess blasts in transformation;hematopoietic ;Myelodysplastic syndrome;1984
9985;Preferred;Myelodysplastic syndrome with multilineage dysplasia;hematopoietic ;Myelodysplastic syndrome;1985
9986;Preferred;Myelodysplastic syndrome with isolated del (5q);hematopoietic ;Myelodysplastic syndrome;1986
9987;Preferred;Therapy-related myelodysplastic syndrome;hematopoietic ;Myelodysplastic syndrome;1987
9989;Preferred;Myelodysplastic syndrome;hematopoietic ;Myelodysplastic syndrome;1989
